| Player | Sat 2/4 | Rank | Traditional Week 26 | Shooting | Rebounding | Fantasy | Availability | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Opp | FPts | Draft | Pts | Ast | TO | Stl | Blk | FG% | FT% | 3P% | OReb | DReb | Reb | FPts | Avg | % Own | |||||||
SG/F NYK | 39.5 | 35 | 17 | 2 | 2 | 1 | 0 | 8/11 | 0/0 | 1/2 | 5 | 5 | 10 | 41.1 | 41.1 | |||||||||
F PHI | — | 19 | 21 | 4 | 1 | 0 | 1 | 9/14 | 0/0 | 3/3 | 2 | 2 | 4 | 46.2 | 46.2 | |||||||||
C NYK | 31.2 | 31 | 8 | 0 | 0 | 0 | 0 | 2/3 | 4/4 | 0/0 | 2 | 3 | 5 | 17 | 17 | |||||||||
PG ORL | — | 73 | — | |||||||||||||||||||||
DTDJa Morant PG MEM | — | 18 | 2 | 6 | 2 | 0 | 8/14 | 0/0 | 2/3 | 0 | 6 | 6 | 35.6 | 35.6 | ||||||||||
SG/F CHI | 57.6 | 13 | 24.5 | 6 | 1.5 | 0.5 | 1 | 10/19 | 6/7 | 0/2 | 1.5 | 4 | 5.5 | 90.6 | 45.3 | |||||||||
PG SAC | — | 16 | 38 | 5 | 3 | 3 | 0 | 13/27 | 8/12 | 4/8 | 1 | 0 | 1 | 62 | 62 | |||||||||
F BOS | — | 3 | 25 | 2 | 2 | 0 | 0 | 10/23 | 2/2 | 3/7 | 0 | 11 | 11 | 51.1 | 51.1 | |||||||||
C ATL | 27.25 | 36 | 8 | 0.5 | 0.5 | 0.5 | 1 | 4/6 | 0/2 | 0/0 | 4 | 10.5 | 14.5 | 65.8 | 32.9 | |||||||||
G/SF DET | 33.6 | 96 | 5 | 1 | 0 | 0 | 1 | 1/4 | 2/2 | 1/4 | 1 | 4 | 5 | 18.8 | 18.8 | |||||||||
G BKN | 30 | 31 | 14 | 3 | 1.5 | 0.5 | 0 | 4/9 | 5/5 | 2/4 | 0 | 2.5 | 2.5 | 58.3 | 29.1 | |||||||||
DTDJimmy Butler F MIA | 56.4 | 9 | 29 | 7.7 | 2.7 | 2.3 | 0.3 | 11/23 | 8/10 | 0/1 | 0.7 | 4 | 4.7 | 155.65 | 51.9 | |||||||||
DTDJordan Poole G WAS | 6.3 | 39 | 17 | 3 | 1 | 0 | 1 | 4/10 | 7/8 | 2/5 | 0 | 1 | 1 | 30.9 | 30.9 | |||||||||
SG/F DET | 33.3 | 2.5 | 1.5 | 0.5 | 1 | 0 | 1/5 | 0/0 | 1/3 | 0 | 3.5 | 3.5 | 24.4 | 12.2 | ||||||||||
G/SF NYK | 32.1 | 28 | 10 | 4 | 1 | 0 | 0 | 3/5 | 2/2 | 2/4 | 1 | 2 | 3 | 27.7 | 27.7 | |||||||||
PF/C ATL | 22.3 | 67 | 7.5 | 1.5 | 0 | 0 | 2 | 3/5 | 3/3 | 0/0 | 3 | 1.5 | 4.5 | 42.4 | 21.2 | |||||||||
SG/SF GSW | 25.9 | 55 | 21 | 5 | 1 | 1 | 0 | 8/19 | 0/0 | 5/14 | 0 | 6 | 6 | 53.5 | 53.5 | |||||||||
F UTA | — | 33 | — | |||||||||||||||||||||
F SAS | — | 37 | — | |||||||||||||||||||||
SG/F ORL | — | 16 | — | |||||||||||||||||||||